TNB Tech Minute: Anthropic Raising $10 Billion In New Funding Round
WSJ Tech News Briefing
The Wall Street Journal
4.3 • 1.7K Ratings
🗓️ 7 January 2026
⏱️ 3 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | AI is transforming industries, but the data centers powering it require more energy and water than ever. |
| 0:06.0 | At the break, join Christoph Beck, chairman and CEO of EcoLab, for insights on using water effectively |
| 0:11.5 | while safeguarding this critical resource for future generations. |
| 0:16.3 | Here's your afternoon, TNB Tech Minute, for Wednesday, January 7th. |
| 0:20.5 | I'm Julie Chang for the Wall Street Journal. |
| 0:22.8 | We exclusively report that Anthropic is raising $10 billion in a new funding round that would nearly |
| 0:28.8 | double its valuation from four months ago. According to people familiar with the matter, |
| 0:33.7 | the new financing will be led by Singapore's sovereign wealth fund and Koto management. |
| 0:38.6 | The AI startup's valuation is at $350 billion before the new investment. |
| 0:43.9 | The round is expected to close in the coming weeks and the total amount of the deal could change. |
| 0:49.5 | Character AI and Google have agreed to settle several lawsuits with families of teenagers who killed or harmed |
| 0:55.8 | themselves after interacting with the startup's chatbot. The lawsuits filed in states, including |
| 1:00.8 | Florida, Colorado, Texas, and New York alleged negligence and harm. According to court documents |
| 1:06.6 | made public yesterday and today, the companies and families are working on settlement terms. |
| 1:11.6 | The tech companies and lawyers for the families either didn't immediately respond to request |
| 1:15.3 | for comment or decline to comment. Character AI is a role-playing app that lets users create |
| 1:20.6 | and chat with AI characters, Google licensed characters technology in 2024. |
| 1:26.4 | Finally, Eli Lilly is in advanced talks to acquire biotech |
| 1:29.7 | Ventex biosciences for around $1 billion. People familiar with the matter say a deal for Ventex |
| 1:35.7 | could come as soon as today. Ventix specializes in developing pills that can treat inflammatory |
| 1:40.9 | diseases. If Ventix's experimental pills pan out, they would add to |
| 1:45.1 | Lily's portfolio of treatments for autoimmune conditions as well as for obesity and related disorders. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Wall Street Journal, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Wall Street Journal and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

